We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» James M. Mason
James M. Mason
Products
PRODUCTS
Mylan Pharmaceuticals, Inc.
Ileana Barreto-Pettit
,
James M. Mason
,
Marcus A. Ray
, and
Melissa T. Roy
Price:
$117.00
View
Accupac, Inc.
James M. Mason
and
David A. Oluwo
Price:
$117.00
View
US Specialty Formulations LLC
James M. Mason
Price:
$117.00
View
Hayward Laboratories, Inc.
James M. Mason
Price:
$117.00
View
Copperhead Chemical Co., Inc.
James M. Mason
Price:
$117.00
View
Troy Manufacturing, Inc.
James M. Mason
Price:
$117.00
View
Spray-Tek, Inc.
James M. Mason
Price:
$117.00
View
Dorneyville Pharmacy
James M. Mason
Price:
$117.00
View
Lehigh Valley Technologies, Inc.
James M. Mason
Price:
$117.00
View
McNeil Consumer Pharmaceutical Healthcare
Thomas E. Friel
and
James M. Mason
Price:
$117.00
View
View All Products by James M. Mason
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
From QSR to QMSR: Meeting FDA’s New Requirements
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
